Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jill Anderson

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
International Journal of Population Data Science|March 20, 2026
The health informatics centre: a safe haven and trusted research environment enabling world-leading researchLaura M Ward, Jenny Johnston, Keith R Milburn, et al.
Journal of the American College of Cardiology|April 15, 2014
Use of the 6-min walk distance to identify variations in treatment benefits from implantable cardioverter-defibrillator and amiodarone: results from the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial)Daniel P Fishbein, Anne S Hellkamp, Daniel B Mark, et al.
Journal of Cardiovascular Electrophysiology|April 1, 2008
Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure TrialAndrea M Russo, Jeanne E Poole, Daniel B Mark, et al.
American Heart Journal|June 2, 2007
Where patients with mild to moderate heart failure die: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)Brian Olshansky, Freda Wood, Anne S Hellkamp, et al.
Heart Rhythm|June 23, 2015
SCD-HeFT: Use of R-R interval statistics for long-term risk stratification for arrhythmic sudden cardiac deathWan-Tai M Au-Yeung, Per G Reinhall, Jeanne E Poole, et al.
JACC. Clinical Electrophysiology|August 25, 2018
Improving the Use of Primary Prevention Implantable Cardioverter-Defibrillators Therapy With Validated Patient-Centric Risk EstimatesWayne C Levy, Anne S Hellkamp, Daniel B Mark, et al.
Heart Rhythm|October 2, 2010
An ECG index of myocardial scar enhances prediction of defibrillator shocks: an analysis of the Sudden Cardiac Death in Heart Failure TrialDavid G Strauss, Jeanne E Poole, Galen S Wagner, et al.
Resuscitation|September 9, 2021
Outcomes for patients with anterior myocardial infarction and prior cardiac arrest in the home automated external defibrillator trial (HAT)Monique Anderson Starks, Larry R Jackson, Anne Hellkamp, et al.
American Heart Journal|November 27, 2008
Ejection fraction assessment and survival: an analysis of the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)Lorne J Gula, George J Klein, Anne S Hellkamp, et al.
Circulation|July 5, 2006
Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)Daniel B Mark, Charlotte L Nelson, Kevin J Anstrom, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
International Journal of Population Data Science|March 20, 2026
The health informatics centre: a safe haven and trusted research environment enabling world-leading researchLaura M Ward, Jenny Johnston, Keith R Milburn, et al.
Journal of the American College of Cardiology|April 15, 2014
Use of the 6-min walk distance to identify variations in treatment benefits from implantable cardioverter-defibrillator and amiodarone: results from the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial)Daniel P Fishbein, Anne S Hellkamp, Daniel B Mark, et al.
Journal of Cardiovascular Electrophysiology|April 1, 2008
Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure TrialAndrea M Russo, Jeanne E Poole, Daniel B Mark, et al.
American Heart Journal|June 2, 2007
Where patients with mild to moderate heart failure die: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)Brian Olshansky, Freda Wood, Anne S Hellkamp, et al.
Heart Rhythm|June 23, 2015
SCD-HeFT: Use of R-R interval statistics for long-term risk stratification for arrhythmic sudden cardiac deathWan-Tai M Au-Yeung, Per G Reinhall, Jeanne E Poole, et al.
JACC. Clinical Electrophysiology|August 25, 2018
Improving the Use of Primary Prevention Implantable Cardioverter-Defibrillators Therapy With Validated Patient-Centric Risk EstimatesWayne C Levy, Anne S Hellkamp, Daniel B Mark, et al.
Heart Rhythm|October 2, 2010
An ECG index of myocardial scar enhances prediction of defibrillator shocks: an analysis of the Sudden Cardiac Death in Heart Failure TrialDavid G Strauss, Jeanne E Poole, Galen S Wagner, et al.
Resuscitation|September 9, 2021
Outcomes for patients with anterior myocardial infarction and prior cardiac arrest in the home automated external defibrillator trial (HAT)Monique Anderson Starks, Larry R Jackson, Anne Hellkamp, et al.
American Heart Journal|November 27, 2008
Ejection fraction assessment and survival: an analysis of the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)Lorne J Gula, George J Klein, Anne S Hellkamp, et al.
Circulation|July 5, 2006
Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)Daniel B Mark, Charlotte L Nelson, Kevin J Anstrom, et al.
Pageof 7